Product-specific research context

What Retatrutide is and why it appears in research literature

A synthetic peptide investigated as a single-molecule agonist at GIP, GLP-1 and glucagon receptors. Avion separates receptor-pharmacology context from any consumer or treatment guidance. GIP receptor signalling; GLP-1 receptor signalling; Glucagon receptor signalling and multi-receptor pharmacology. This 30mg presentation includes one prefilled research pen and 5 × 32G needles, with the compound and strength clearly identified. This page separates published compound identity from batch-specific analytical claims so that formulae, purity and supplied form are not inferred where the source record does not support them.